Funding for this research was provided by:
National Institute on Aging (R01AG058501, R01AG057777, R01AG044546, RF1AG053303, U01AG058922, RF1AG058501)
Received: 20 November 2018
Accepted: 26 April 2019
First Online: 8 May 2019
Ethics approval and consent to participate
: The protocol of Knight-ADRC studies have been approved by the review board of Washington University in St. Louis. The protocol of Mayo dataset was approved by the Mayo Clinic Institutional Review Board (IRB). All neuropsychological, diagnostic and autopsy protocols of MSSM dataset were approved by the Mount Sinai and JJ Peters VA Medical Center Institutional Review Boards. The MSSM sample protocol was approved by Icahn School of Medicine at Mount Sinai IRB; All participants were recruited with informed consent for research use.
: Not applicable
: CC receives research support from: Biogen, EISAI, Alector and Parabon. The funders of the study had no role in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. CC is a member of the advisory board of ADx Healthcare, and Vivid Genomics.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.